Transform Healthcare via AI Technology

Healthcare technology sector is undergoing a generational shift. AI-enabled diagnostics, precision oncology, and digital pathology are moving from research labs into clinical practice — and the companies leading this transformation are competing fiercely for a narrow pool of people who understand both the science and the commercial reality. We know this market. We've mapped it, we recruit inside it, and we help clients build teams that can actually execute.

Where is the market moving?
Our market intelligence spans the full spectrum — from well-capitalised players like Owkin, Perspectum, and Brainomix through to the new wave of AI-first startups reshaping what diagnostics means.

Five primary clusters account for the majority of qualified candidates in this space, and understanding how people move between institutions, spinouts, and growth-stage companies within each cluster is central to our recruiting. Cambridge is the densest concentration, spanning digital pathology, oncology, and molecular diagnostics — driven by university spinouts and the gravitational pull of Cancer Research UK funding. London sits alongside it as the hub for AI infrastructure, oncology therapeutics, and the commercial talent those companies need to scale. Paris has emerged as Europe's leading centre for AI foundation model approaches to diagnostics, with particular strength in radiology AI. Barcelona anchors Southern Europe's ecosystem, specialising in oncology diagnostics and biomarker-driven IVD. Finally, the Belgian Flanders–Wallonia corridor has established itself as a distinct cluster for radiopharmaceuticals and imaging AI, punching well above its size relative to the broader European market.